Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000779164 | SCV000915681 | likely pathogenic | Thyroid dyshormonogenesis 6 | 2024-07-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001873181 | SCV002234810 | pathogenic | not provided | 2024-06-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.His1223Thrfs*18) in the DUOX2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DUOX2 are known to be pathogenic (PMID: 12110737, 18765513, 21565790, 24423310, 24735383). This variant is present in population databases (rs754179275, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with congenital hypothyroidism (PMID: 29650690). ClinVar contains an entry for this variant (Variation ID: 632237). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001873181 | SCV003914974 | likely pathogenic | not provided | 2022-10-06 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 29650690, 34200080) |
Fulgent Genetics, |
RCV000779164 | SCV005637788 | likely pathogenic | Thyroid dyshormonogenesis 6 | 2024-01-23 | criteria provided, single submitter | clinical testing |